References
- Rocha AO, Azevedo RC, Silva VA, et al. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res. 2019;8:565–511.
- Ding T, Hardiman PJ, Petersen I, et al. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351–96358.
- Bates GW, Jr., Propst AM. Polycystic ovarian syndrome management options. Obstet Gynecol Clin North Am. 2012;39(4):495–506.
- Agarwal A, Sengupta P, Durairajanayagam D. Role of L-carnitine in female infertility. Reprod Biol Endocrinol. 2018;16(1):5
- Fenkci SM, Fenkci V, Oztekin O, et al. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod. 2008;23(7):1602–1606.
- Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med. 2004;25(5–6):455–473.
- Vanella A, Russo A, Acquaviva R, et al. L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol. 2000;16(2):99–104.
- Miyamoto K, Sato EF, Kasahara E, et al. Effect of oxidative stress during repeated ovulation on the structure and functions of the ovary, oocytes, and their mitochondria. Free Radic Biol Med. 2010;49(4):674–681.
- Kalhori Z, Mehranjani MS, Azadbakht M, et al. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. Reprod Fertil Dev. 2019;31(2):282–293.
- Wf G. The effect of adding L-Carnitine to induction of ovulation with letrozole among PCOS patients. Austin J Obstetr Gynecol. 2019;6(3):1141–1144.
- Guideline E. Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003;19(1):41–47.
- Aflatoonian N, Pourmasumi S, Aflatoonian A, et al. Duration of storage does not influence pregnancy outcome in cryopreserved human embryos. Iran J Reprod Med. 2013;11(10):843–846.
- Samimi M, Jamilian M, Ebrahimi FA, et al. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol. 2016;84(6):851–857.
- Ismail AM, Hamed AH, Saso S, et al. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014;180:148–152.
- Abd-Elfattah AH, Elomda FAE, Megahed HI. Effect of adding L-Carnitine to clomiphene resistant PCOs women on the ovulation and the pregnancy rate. Egyptian J Hosp Med. 2019;76(5):4138–4143.
- Kortam M, Abdelrahman R, Fateen H. Carnitine and clomiphene citrate for induction of ovulation in women with polycystic ovary syndrome: randomized controlled trial. Evidence Based Women's Health J. 2020;10(1):1–7.
- El Sharkwy I, Sharaf El-Din M. l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial. Gynecol Endocrinol. 2019;35(8):701–705.
- Kitano Y, Hashimoto S, Matsumoto H, et al. Oral administration of l-carnitine improves the clinical outcome of fertility in patients with IVF treatment. Gynecol Endocrinol. 2018;34(8):684–688.
- Salehpour S, Nazari L, Hoseini S, et al. Effects of L-carnitine on polycystic ovary syndrome. JBRA Assist Reprod. 2019;23(4):392–395.
- Moawad AR, Tan SL, Xu B, et al. L-carnitine supplementation during vitrification of mouse oocytes at the germinal vesicle stage improves preimplantation development following maturation and fertilization in vitro. Biol Reprod. 2013;88(4):104
- Moawad AR, Xu B, Tan SL, et al. L-carnitine supplementation during vitrification of mouse germinal vesicle stage-oocytes and their subsequent in vitro maturation improves meiotic spindle configuration and mitochondrial distribution in metaphase II oocytes. Hum Reprod. 2014;29(1010):2256–2268.